AL
Adam Scott Levy (CFO and Secretary) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $5.3M of MLYS (116,948 sh across 7 lots, as filed), executed Nov 11 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$346K
shares × price, as filed
Last traded
Jan 12
Filed Jan 13
Median ADV $38.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
MLYS
Mineralys Therapeutics, Inc.
MLYS · 0 buys · 6 sells
6 filings
Recent filings
MLYSSALE
Mineralys Therapeutics, Inc.
View filing →
$346K10,758 sh × $32.14
Exec Jan 12
Filed Jan 13 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $5.3M
116,948 sh across 7 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $452K
10,758 sh across 2 lots
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $1.1M
72,871 sh across 3 lots
Exec Jul 28 2025
Filed Jul 30 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $155K
10,758 sh × $14.45
Exec Jul 11 2025
Filed Jul 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $130K
10,757 sh × $12.06
Exec Apr 11 2025
Filed Apr 15 2025 · 5:30 PM ET